In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry.
Esposito S, Pagliano P, De Simone G, Guarino A, Pan A, Brambilla P, Mastroianni C, Lichtner M, Brugnaro P, Carretta A, Santantonio T, Brindicci G, Carrega G, Montagnani F, Lapadula G, Spolti A, Luzzati R, Schiaroli E, Scaglione V, Pallotto C, Tacconi D, Quintieri F, Trecarichi E; Italian Society of Infectious, Tropical Diseases.
Esposito S, et al.
Infection. 2024 Feb 7. doi: 10.1007/s15010-024-02176-2. Online ahead of print.
Infection. 2024.
PMID: 38324144